U.S. markets close in 1 hour 43 minutes
  • S&P 500

    4,151.43
    -22.42 (-0.54%)
     
  • Dow 30

    34,278.26
    -103.87 (-0.30%)
     
  • Nasdaq

    13,296.51
    -133.47 (-0.99%)
     
  • Russell 2000

    2,214.06
    -10.57 (-0.48%)
     
  • Crude Oil

    66.29
    +0.92 (+1.41%)
     
  • Gold

    1,868.90
    +30.80 (+1.68%)
     
  • Silver

    28.42
    +1.05 (+3.84%)
     
  • EUR/USD

    1.2162
    +0.0016 (+0.13%)
     
  • 10-Yr Bond

    1.6370
    +0.0020 (+0.12%)
     
  • GBP/USD

    1.4143
    +0.0041 (+0.29%)
     
  • USD/JPY

    109.1440
    -0.2030 (-0.19%)
     
  • BTC-USD

    43,098.75
    -3,885.79 (-8.27%)
     
  • CMC Crypto 200

    1,191.27
    -6.65 (-0.56%)
     
  • FTSE 100

    7,032.85
    -10.76 (-0.15%)
     
  • Nikkei 225

    27,824.83
    -259.67 (-0.92%)
     

Company News For Nov 26, 2019

Zacks Equity Research
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
  • Shares of Aquestive Therapeutics, Inc. AQST gained 17.3% after the specialty pharmaceutical company received the FDA approval for EXSERVAN for the treatment of amyotrphic lateral sclerosis.

  • Shares of Intercept Pharmaceuticals, Inc. ICPT rose 8.4% after the FDA accepted Intercept’s New Drug Application for obeticholic acid for the treatment of Liver Fibrosis.

  • Shares of CymaBay Therapeutics, Inc. CBAY declined 76% after the clinical-stage biopharmaceutical company halted the clinical development of Seladelpar.

  • Shares of Surface Oncology, Inc. SURF lost 21% after clinical-stage immuno-oncology company reported a $25 million debt financing from K2 HealthVentures.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Intercept Pharmaceuticals, Inc. (ICPT) : Free Stock Analysis Report
 
CymaBay Therapeutics Inc. (CBAY) : Free Stock Analysis Report
 
Surface Oncology, Inc. (SURF) : Free Stock Analysis Report
 
Aquestive Therapeutics, Inc. (AQST) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research